HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Eric Chun Yong Chan Selected Research
Eric Chun Yong Chan Research Topics
Disease
11
Neoplasms (Cancer)
01/2022 - 07/2010
10
Atrial Fibrillation
10/2023 - 01/2016
7
Hemorrhage
10/2023 - 06/2021
5
Infections
01/2023 - 02/2013
4
Stroke (Strokes)
10/2023 - 01/2017
4
Inflammation (Inflammations)
04/2023 - 01/2009
4
Cholangiocarcinoma
05/2022 - 01/2021
4
Mitochondrial Diseases (Mitochondrial Disease)
04/2022 - 06/2010
4
Breast Neoplasms (Breast Cancer)
01/2017 - 10/2010
4
Colorectal Neoplasms (Colorectal Cancer)
10/2015 - 03/2011
3
COVID-19
04/2024 - 01/2022
3
Colitis
01/2023 - 04/2022
3
Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 02/2015
3
Alzheimer Disease (Alzheimer's Disease)
02/2017 - 12/2012
2
Type 2 Diabetes Mellitus (MODY)
04/2023 - 02/2010
2
Atopic Dermatitis (Atopic Eczema)
01/2023 - 11/2020
2
Venous Thromboembolism
01/2022 - 01/2022
2
Gout
01/2021 - 01/2021
2
Heart Failure
01/2021 - 01/2018
1
Embolism (Embolus)
10/2023
1
Torsades de Pointes (Torsade de Pointes)
08/2023
1
Insulin Resistance
04/2023
1
Glucose Intolerance
04/2023
1
Prostatic Neoplasms (Prostate Cancer)
01/2023
1
Chemical and Drug Induced Liver Injury
12/2022
1
Cardiovascular Diseases (Cardiovascular Disease)
10/2022
1
Critical Illness (Critically Ill)
10/2022
1
Hepatocellular Carcinoma (Hepatoma)
04/2022
1
Eczema
01/2022
1
Respiratory Sounds (Crackle)
01/2022
Drug/Important Bio-Agent (IBA)
9
Rivaroxaban
IBA
10/2023 - 01/2017
8
Dronedarone
FDA Link
01/2023 - 01/2016
5
Anticoagulants
IBA
10/2022 - 06/2021
4
Proteins (Proteins, Gene)
FDA Link
04/2023 - 01/2014
4
Biomarkers (Surrogate Marker)
IBA
01/2021 - 07/2014
4
Lapatinib (GW572016)
FDA Link
01/2017 - 10/2010
3
Amiodarone (Amiodarona)
FDA Link
Generic
01/2023 - 06/2021
3
Acids
IBA
01/2023 - 01/2018
3
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
01/2022 - 01/2021
3
Troglitazone (Rezulin)
FDA Link
12/2012 - 02/2010
2
nirmatrelvir and ritonavir drug combination
IBA
04/2024 - 10/2022
2
Cytochrome P-450 CYP2J2 (CYP2J2)
IBA
08/2023 - 01/2017
2
Enzymes
IBA
04/2023 - 01/2023
2
Dextran Sulfate
IBA
01/2023 - 01/2023
2
Cytochrome P-450 Enzyme System (Cytochrome P450)
IBA
12/2022 - 06/2011
2
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
05/2022 - 01/2021
2
futibatinib
IBA
05/2022 - 01/2022
2
poyendarone
IBA
04/2022 - 01/2021
2
infigratinib
IBA
01/2022 - 01/2021
2
Allergens
IBA
01/2022 - 11/2020
2
Fructose
IBA
12/2021 - 04/2014
2
Uricosuric Agents
IBA
01/2021 - 01/2021
2
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
01/2021 - 11/2020
2
Kynurenine
IBA
01/2021 - 09/2013
2
Benzbromarone
IBA
01/2021 - 01/2021
2
Tryptophan (L-Tryptophan)
FDA Link
01/2021 - 09/2013
2
Glucose (Dextrose)
FDA Link
Generic
11/2020 - 11/2015
2
Docosahexaenoic Acids
IBA
02/2017 - 01/2014
2
Cholesterol
IBA
02/2017 - 01/2014
2
Amyloid (Amyloid Fibrils)
IBA
02/2017 - 01/2014
2
Anti-Bacterial Agents (Antibiotics)
IBA
01/2017 - 02/2013
2
Polymyxin B (Aerosporin)
FDA Link
Generic
01/2017 - 01/2016
2
Tigecycline (Tygacil)
FDA Link
01/2016 - 05/2015
2
Tyrosine Kinase Inhibitors
IBA
07/2012 - 10/2010
2
Hypoglycemic Agents (Hypoglycemics)
IBA
06/2010 - 02/2010
1
apixaban
IBA
10/2023
1
Atorvastatin (Lipitor)
FDA Link
10/2023
1
Simvastatin (Zocor)
FDA Link
Generic
10/2023
1
Creatinine
IBA
10/2023
1
Messenger RNA (mRNA)
IBA
04/2023
1
Lipids
IBA
04/2023
1
Blood Glucose (Blood Sugar)
IBA
04/2023
1
Hormones (Hormone)
IBA
04/2023
1
abiraterone
IBA
01/2023
1
Interleukin-17 (Interleukin 17)
IBA
01/2023
1
Micronutrients
IBA
01/2023
1
Volatile Fatty Acids
IBA
01/2023
1
Ketoconazole (Nizoral)
FDA Link
Generic
01/2023
1
Anti-Arrhythmia Agents
IBA
10/2022
1
Cytokines
IBA
04/2022
1
Interleukin-10 (Interleukin 10)
IBA
04/2022
1
N-desbutyldronedarone
IBA
04/2022
1
benzofuran
IBA
04/2022
1
Febuxostat
FDA Link
04/2022
1
desethylamiodarone
IBA
04/2022
1
Factor Xa (Coagulation Factor Xa)
IBA
04/2022
1
Butyric Acid (Butanoic Acid)
IBA
01/2022
1
propionic acid (potassium propionate)
IBA
01/2022
1
tofacitinib
IBA
01/2022
1
nilotinib
FDA Link
01/2022
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2022
1
Janus Kinase Inhibitors
IBA
01/2022
1
Immunomodulating Agents
IBA
01/2022
1
baricitinib
IBA
01/2022
1
Protein Kinase Inhibitors
IBA
01/2022
1
Janus Kinases
IBA
01/2022
Therapy/Procedure
8
Therapeutics
10/2022 - 12/2012
2
Drug Tapering
01/2023 - 01/2022
2
Drug Therapy (Chemotherapy)
11/2019 - 03/2013
1
Fecal Microbiota Transplantation
04/2022